OACC
Oaktree Acquisition Corp. III Life SciencesCompany Information
- Company Name
- Oaktree Acquisition Corp. III Life Sciences
- CIK
- CIK0002029769
- Category
- Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
- Ticker: Exchange
- OACC: Nasdaq, OACCU: Nasdaq, OACCW: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 05 Real Estate & Construction
- SIC
- 6770
- SIC Description
- Blank Checks
- Ticker
- OACC
SEC filing data through
Insider Sentiment
- Last purchase
- —
- Last sale
- —
- Shares purchased (TTM)
- 0
- Shares sold (TTM)
- 0
Institutional Sentiment
- As of
- —
- Institutional shares owned
- —
- Shares outstanding
- —
- Ownership
- —
Earnings Market Reaction
- Filing date
- 2026-08-12
- Price on filing date
- —
- 1-month reaction
- 0.37%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | ||||||||||||
| Cash And Cash Equivalents At Carrying Value | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Prepaid Expense Current | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Assets Current | 1 | 1 | 2 | 1 | 2 | 1 | ||||||
| Prepaid Expense Noncurrent | - | - | 0 | 0 | 0 | 0 | ||||||
| Assets Held In Trust Noncurrent | 205 | 203 | 202 | 200 | 198 | 196 | ||||||
| Assets | 207 | 205 | 203 | 201 | 199 | 197 | ||||||
Liabilities Current | ||||||||||||
| Accounts Payable And Accrued Liabilities Current | 1 | 1 | 1 | 0 | 0 | 0 | ||||||
| Notes Payable Current | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Liabilities Current | 2 | 2 | 1 | 1 | 1 | 1 | ||||||
| Liabilities | 9 | 9 | 8 | 8 | 8 | 8 | ||||||
| Temporary Equity Carrying Amount Attributable To Parent | 205 | 203 | 202 | 200 | 198 | 196 | ||||||
Stockholders Equity | ||||||||||||
| Preferred Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Retained Earnings Accumulated Deficit | -7 | -7 | -7 | -7 | -7 | -7 | ||||||
| Stockholders Equity | -7 | -7 | -7 | -7 | -7 | -7 | ||||||
| Liabilities And Stockholders Equity | 207 | 205 | 203 | 201 | 199 | 197 | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Preferred Stock Shares Authorized | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Select a line item above to chart it.
Recent filings
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialOaktree Acquisition Corp. III Life Sciences (OACC) — SEC Financial Statements & Analysis
Oaktree Acquisition Corp. III Life Sciences (OACC) is a blank checks company, incorporated in E9. Oaktree Acquisition Corp. III Life Sciences trades on Nasdaq as: OACC, OACCU, OACCW. Oaktree Acquisition Corp. III Life Sciences (OACC)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-12. Based on that filing, Oaktree Acquisition Corp. III Life Sciences carries a market cap of $205.43M, a P/E ratio of 30.41x, a P/B ratio of -27.43x, an enterprise value of $204.26M, and an EV/EBITDA multiple of -170.28x. On profitability, it posts a Return on Equity (ROE) of -96.30% and a Return on Assets (ROA) of 3.33%. Per share, it reports EPS of $0.35, free cash flow per share of $-0.02, and a dividend per share of $0.00. On the balance sheet, it maintains a current ratio of 0.73x, a quick ratio of 0.68x, working capital of $-469.90K, a debt-to-equity ratio of -1.17x, a debt ratio of 0.04, free cash flow of $-455.69K (TTM), and net debt of $-1.17M. Figures sourced from SEC EDGAR.
- Market Cap
- $205.43M
- P/E TTM
- 30.41x
- EPS TTM
- $0.35
- P/B TTM
- -27.43x
- ROE TTM
- -96.30%
- ROA TTM
- 3.33%
- Debt To Equity
- -1.17x
- Free Cash Flow TTM
- $-455.69K
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Oaktree Acquisition Corp. III Life Sciences in?
Oaktree Acquisition Corp. III Life Sciences (OACC) operates in the Blank Checks industry.
What exchange does OACC trade on?
Oaktree Acquisition Corp. III Life Sciences (OACC) trades on the Nasdaq.
Where is Oaktree Acquisition Corp. III Life Sciences incorporated?
Oaktree Acquisition Corp. III Life Sciences is incorporated in Cayman Islands.
When was Oaktree Acquisition Corp. III Life Sciences (OACC)'s most recent SEC filing?
Oaktree Acquisition Corp. III Life Sciences (OACC)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-12.
What is OACC's market cap?
Oaktree Acquisition Corp. III Life Sciences (OACC) has a market capitalization of $205.43M as of 2026-06-30.
What is OACC's P/E ratio?
Oaktree Acquisition Corp. III Life Sciences (OACC)'s trailing twelve month P/E ratio is 30.41x as of 2026-06-30.
What is OACC's EPS (earnings per share)?
Oaktree Acquisition Corp. III Life Sciences (OACC)'s trailing twelve month EPS is $0.35 as of 2026-06-30.
What is OACC's ROE (return on equity)?
Oaktree Acquisition Corp. III Life Sciences (OACC)'s trailing twelve month Return on Equity (ROE) is -96.30% as of 2026-06-30.
What is OACC's ROA (return on assets)?
Oaktree Acquisition Corp. III Life Sciences (OACC)'s trailing twelve month Return on Assets (ROA) is 3.33% as of 2026-06-30.
What is OACC's EV/EBITDA?
Oaktree Acquisition Corp. III Life Sciences (OACC)'s trailing twelve month EV/EBITDA is -170.28x as of 2026-06-30.